Literature DB >> 23671516

Ambulant monitoring of bladder oxygenation and hemodynamics using wireless near-infrared spectroscopy.

Andrew John Macnab1, Babak Shadgan, Lynn Stothers, Kourosh Afshar.   

Abstract

INTRODUCTION: Near-infrared spectroscopy (NIRS) non-invasively detects changes in the concentration of the chromophores oxygenated (ΔO2Hb) and deoxygenated hemoglobin (ΔHHb) as the bladder detrusor muscle contracts during voiding. Such data provide novel information on bladder oxygenation and hemodynamics. We evaluated the feasibility of monitoring ambulant subjects using a wireless NIRS device.
METHODS: The wireless device uses paired light-emitting diodes (wavelengths 760 and 850 nm) and a silicon photodiode detector. We monitored 14 asymptomatic subjects (10 adults, 4 children) and 6 symptomatic children with non-neurogenic lower urinary tract dysfunction (NLUTD) during spontaneous voiding after natural filling. The device was taped to the abdominal skin 2 cm above the symphysis pubis across the midline. The wireless NIRS data (patterns of change in chromophore concentration) were compared between subjects and to the data obtained using a laser-powered instrument.
RESULTS: Graphs of ΔO2Hb, ΔHHb and total hemoglobin (ΔtHb) were obtained from all 20 patients. Data during uroflow showed reproducible patterns of bladder chromophore change between asymptomatic subjects (rise in ΔtHb/ΔO2Hb), consistent with laser instrument data. In contrast, all 6 symptomatic children had a negative trend in ΔtHb, with falls in ΔO2Hb. One adult experienced "shy" bladder and changes in hemodynamics/oxygenation occurred while bladder volume was unchanged.
CONCLUSIONS: Wireless NIRS bladder monitoring is feasible in ambulant adults and children; wireless and laser-derived data in asymptomatic subjects are comparable. Pilot data suggest that subjects with symptomatic NLUTD have impaired bladder oxygenation/hemodynamics. The fact that chromophore changes occur when bladder volume remains constant supports the concept that NIRS data are a physiologic measure.

Entities:  

Year:  2013        PMID: 23671516      PMCID: PMC3650823          DOI: 10.5489/cuaj.271

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  12 in total

Review 1.  Principles, techniques, and limitations of near infrared spectroscopy.

Authors:  Marco Ferrari; Leonardo Mottola; Valentina Quaresima
Journal:  Can J Appl Physiol       Date:  2004-08

Review 2.  Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications.

Authors:  Martin Wolf; Marco Ferrari; Valentina Quaresima
Journal:  J Biomed Opt       Date:  2007 Nov-Dec       Impact factor: 3.170

3.  Editorial comment on: classification of male lower urinary tract symptoms using mathematical modelling and a regression tree algorithm of noninvasive near-infrared spectroscopy parameters.

Authors:  Jürgen Pannek
Journal:  Eur Urol       Date:  2009-05-13       Impact factor: 20.096

4.  Dynamic topographic mapping of the human bladder during voiding using functional near-infrared spectroscopy.

Authors:  Andrew Macnab; Lynn Stothers; Babak Shadgan
Journal:  J Biomed Opt       Date:  2009 Mar-Apr       Impact factor: 3.170

Review 5.  Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease.

Authors:  R Boushel; H Langberg; J Olesen; J Gonzales-Alonzo; J Bülow; M Kjaer
Journal:  Scand J Med Sci Sports       Date:  2001-08       Impact factor: 4.221

6.  The status of pelvic floor muscle training for women.

Authors:  Andrea Marques; Lynn Stothers; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2010-12       Impact factor: 1.862

7.  Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptoms.

Authors:  Doreen E Chung; Richard K Lee; Steven A Kaplan; Alexis E Te
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

Review 8.  Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans.

Authors:  Takafumi Hamaoka; Kevin K McCully; Valentina Quaresima; Katsuyuki Yamamoto; Britton Chance
Journal:  J Biomed Opt       Date:  2007 Nov-Dec       Impact factor: 3.170

9.  Development of a symptom score for dysfunctional elimination syndrome.

Authors:  Kourosh Afshar; Amir Mirbagheri; Heidi Scott; Andrew E MacNeily
Journal:  J Urol       Date:  2009-08-20       Impact factor: 7.450

Review 10.  The microcirculation as a functional system.

Authors:  Christopher G Ellis; Justin Jagger; Michael Sharpe
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

View more
  5 in total

Review 1.  Obstruction-induced alterations within the urinary bladder and their role in the pathophysiology of lower urinary tract symptomatology.

Authors:  Christos Komninos; Iraklis Mitsogiannis
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

2.  Is submucosal bladder pressure monitoring feasible?

Authors:  Anisha S Basu; Steve Majerus; Elizabeth Ferry; Iryna Makovey; Hui Zhu; Margot S Damaser
Journal:  Proc Inst Mech Eng H       Date:  2018-01-29       Impact factor: 1.617

3.  Probing penile hemodynamics by using photoplethysmography as objective indicators for male erection quality and sexual function.

Authors:  Yuan-Hung Pong; Yi-Kai Chang; Ching-En Hsu; Po-Cheng Chen; Yu-Chuan Lu; Vincent F S Tsai; Hong-Chiang Chang; Men-Tzung Lo; Chen Lin
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

4.  Monitoring Detrusor Oxygenation and Hemodynamics Noninvasively during Dysfunctional Voiding.

Authors:  Andrew J Macnab; Lynn S Stothers; Babak Shadgan
Journal:  Adv Urol       Date:  2012-09-18

Review 5.  Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans.

Authors:  Ferdinando Fusco; Massimiliano Creta; Cosimo De Nunzio; Valerio Iacovelli; Francesco Mangiapia; Vincenzo Li Marzi; Enrico Finazzi Agrò
Journal:  BMC Urol       Date:  2018-03-09       Impact factor: 2.264

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.